C07 Strong Ligaments And Joints

Arnica Montana, Ascorbicum Acidum, Bos Taurus Lymph Vessel, Intervertebral Fibrocartilage, Bos Taurus Mesenchyme, Calcarea Phosphorica, Cartilago Suis, Formicum Acidum, Lapis Albus, Pinus Montana Leafy Twig, Rhamnus Californica, Rhus Toxicodendron, Ruta Graveolens, Silicea, Sus Scrofa Joint Envelope, Sus Scrofa Ligament, Sus Scrofa Meniscus, Sus Scrofa Parathyroid Gland, Sus Scrofa Vein, Symphytum Officinale


Apex Energetics Inc.
Human Otc Drug
NDC 63479-0307
C07 Strong Ligaments And Joints also known as Arnica Montana, Ascorbicum Acidum, Bos Taurus Lymph Vessel, Intervertebral Fibrocartilage, Bos Taurus Mesenchyme, Calcarea Phosphorica, Cartilago Suis, Formicum Acidum, Lapis Albus, Pinus Montana Leafy Twig, Rhamnus Californica, Rhus Toxicodendron, Ruta Graveolens, Silicea, Sus Scrofa Joint Envelope, Sus Scrofa Ligament, Sus Scrofa Meniscus, Sus Scrofa Parathyroid Gland, Sus Scrofa Vein, Symphytum Officinale is a human otc drug labeled by 'Apex Energetics Inc.'. National Drug Code (NDC) number for C07 Strong Ligaments And Joints is 63479-0307. This drug is available in dosage form of Solution/ Drops. The names of the active, medicinal ingredients in C07 Strong Ligaments And Joints drug includes Arnica Montana - 12 [hp_X]/mL Ascorbic Acid - 8 [hp_X]/mL Bos Taurus Intervertebral Disc - 8 [hp_C]/mL Bos Taurus Lymph Vessel - 7 [hp_C]/mL Bos Taurus Mesenchyme - 8 [hp_C]/mL Calcium Hexafluorosilicate - 12 [hp_X]/mL Comfrey Root - 9 [hp_X]/mL Formic Acid - 12 [hp_X]/mL Frangula Californica Bark - 8 [hp_X]/mL Pinus Mugo Leafy Twig - 7 [hp_X]/mL and more. The currest status of C07 Strong Ligaments And Joints drug is Active.

Drug Information:

Drug NDC: 63479-0307
The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC.
Proprietary Name: C07 Strong Ligaments And Joints
Also known as the trade name. It is the name of the product chosen by the labeler.
Proprietary Name Base: C07
The base of the Brand/Proprietary name excluding its suffix.
Proprietary Name Suffix: STRONG LIGAMENTS AND JOINTS
A suffix to the proprietary name, a value here should be appended to the ProprietaryName field to obtain the complete name of the product. This suffix is often used to distinguish characteristics of a product such as extended release (“XR”) or sleep aid (“PM”). Although many companies follow certain naming conventions for suffices, there is no recognized standard.
Product Type: Human Otc Drug
Indicates the type of product, such as Human Prescription Drug or Human OTC Drug. This data element corresponds to the “Document Type” of the SPL submission for the listing.
Non Proprietary Name: Arnica Montana, Ascorbicum Acidum, Bos Taurus Lymph Vessel, Intervertebral Fibrocartilage, Bos Taurus Mesenchyme, Calcarea Phosphorica, Cartilago Suis, Formicum Acidum, Lapis Albus, Pinus Montana Leafy Twig, Rhamnus Californica, Rhus Toxicodendron, Ruta Graveolens, Silicea, Sus Scrofa Joint Envelope, Sus Scrofa Ligament, Sus Scrofa Meniscus, Sus Scrofa Parathyroid Gland, Sus Scrofa Vein, Symphytum Officinale
Also known as the generic name, this is usually the active ingredient(s) of the product.
Labeler Name: Apex Energetics Inc.
Name of Company corresponding to the labeler code segment of the ProductNDC.
Dosage Form: Solution/ Drops
The translation of the DosageForm Code submitted by the firm. There is no standard, but values may include terms like `tablet` or `solution for injection`.The complete list of codes and translations can be found www.fda.gov/edrls under Structured Product Labeling Resources.
Status: Active
FDA does not review and approve unfinished products. Therefore, all products in this file are considered unapproved.
Substance Name:ARNICA MONTANA - 12 [hp_X]/mL
ASCORBIC ACID - 8 [hp_X]/mL
BOS TAURUS INTERVERTEBRAL DISC - 8 [hp_C]/mL
BOS TAURUS LYMPH VESSEL - 7 [hp_C]/mL
BOS TAURUS MESENCHYME - 8 [hp_C]/mL
CALCIUM HEXAFLUOROSILICATE - 12 [hp_X]/mL
COMFREY ROOT - 9 [hp_X]/mL
FORMIC ACID - 12 [hp_X]/mL
FRANGULA CALIFORNICA BARK - 8 [hp_X]/mL
PINUS MUGO LEAFY TWIG - 7 [hp_X]/mL
RUTA GRAVEOLENS FLOWERING TOP - 12 [hp_X]/mL
SILICON DIOXIDE - 12 [hp_X]/mL
SUS SCROFA CARTILAGE - 7 [hp_C]/mL
SUS SCROFA JOINT CAPSULE - 8 [hp_C]/mL
SUS SCROFA LIGAMENT - 8 [hp_C]/mL
SUS SCROFA MENISCUS - 7 [hp_C]/mL
SUS SCROFA PARATHYROID GLAND - 8 [hp_C]/mL
SUS SCROFA VEIN - 7 [hp_C]/mL
TOXICODENDRON PUBESCENS LEAF - 15 [hp_X]/mL
TRIBASIC CALCIUM PHOSPHATE - 12 [hp_X]/mL
This is the active ingredient list. Each ingredient name is the preferred term of the UNII code submitted.
Route Details:SUBLINGUAL
The translation of the Route Code submitted by the firm, indicating route of administration. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.

Marketing Information:

An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
Marketing Category: UNAPPROVED HOMEOPATHIC
Product types are broken down into several potential Marketing Categories, such as New Drug Application (NDA), Abbreviated New Drug Application (ANDA), BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
Marketing Start Date: 15 Aug, 1988
This is the date that the labeler indicates was the start of its marketing of the drug product.
Marketing End Date: 20 Dec, 2025
This is the date the product will no longer be available on the market. If a product is no longer being manufactured, in most cases, the FDA recommends firms use the expiration date of the last lot produced as the EndMarketingDate, to reflect the potential for drug product to remain available after manufacturing has ceased. Products that are the subject of ongoing manufacturing will not ordinarily have any EndMarketingDate. Products with a value in the EndMarketingDate will be removed from the NDC Directory when the EndMarketingDate is reached.
Listing Expiration Date: 31 Dec, 2023
This is the date when the listing record will expire if not updated or certified by the firm.

OpenFDA Information:

An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
Manufacturer Name:Apex Energetics Inc.
Name of manufacturer or company that makes this drug product, corresponding to the labeler code segment of the NDC.
Original Packager:Yes
Whether or not the drug has been repackaged for distribution.
UPC:0818960011734
UPC stands for Universal Product Code.
NUI:N0000193618
M0001797
Unique identifier applied to a drug concept within the National Drug File Reference Terminology (NDF-RT).
UNII:O80TY208ZW
PQ6CK8PD0R
0A04Z76C13
85I1Z426OV
3802H34QRI
2NVP93XVQ3
M9VVZ08EKQ
0YIW783RG1
1LZ13MQR0S
787BZ3D14H
N94C2U587S
ETJ7Z6XBU4
73ECW5WG2F
LX0XHE5NLN
2004Q810JO
1C8T78BD9Q
2KBE35NE8S
2510RH3I89
6IO182RP7A
91D9GV0Z28
Unique Ingredient Identifier, which is a non-proprietary, free, unique, unambiguous, non-semantic, alphanumeric identifier based on a substance’s molecular structure and/or descriptive information.
Pharmacologic Class EPC:Vitamin C [EPC]
Established pharmacologic class associated with an approved indication of an active moiety (generic drug) that the FDA has determined to be scientifically valid and clinically meaningful. Takes the form of the pharmacologic class, followed by `[EPC]` (such as `Thiazide Diuretic [EPC]` or `Tumor Necrosis Factor Blocker [EPC]`.
Pharmacologic Class CS:Ascorbic Acid [CS]
Chemical structure classification of the drug product’s pharmacologic class. Takes the form of the classification, followed by `[Chemical/Ingredient]` (such as `Thiazides [Chemical/Ingredient]` or `Antibodies, Monoclonal [Chemical/Ingredient].
Pharmacologic Class:Ascorbic Acid [CS]
Vitamin C [EPC]
These are the reported pharmacological class categories corresponding to the SubstanceNames listed above.

Packaging Information:

Package NDCDescriptionMarketing Start DateMarketing End DateSample Available
63479-0307-130 mL in 1 BOTTLE, GLASS (63479-0307-1)15 Aug, 1988N/ANo
Package NDC number, known as the NDC, identifies the labeler, product, and trade package size. The first segment, the labeler code, is assigned by the FDA. Description tells the size and type of packaging in sentence form. Multilevel packages will have the descriptions concatenated together.

Purpose:

Uses: for temporary relief of minor: joint aches* swelling* bruises* stiff ligaments* *claims based on traditional homeopathic practice, not accepted medical evidence. not fda evaluated.

Product Elements:

C07 strong ligaments and joints arnica montana, ascorbicum acidum, bos taurus lymph vessel, intervertebral fibrocartilage, bos taurus mesenchyme, calcarea phosphorica, cartilago suis, formicum acidum, lapis albus, pinus montana leafy twig, rhamnus californica, rhus toxicodendron, ruta graveolens, silicea, sus scrofa joint envelope, sus scrofa ligament, sus scrofa meniscus, sus scrofa parathyroid gland, sus scrofa vein, symphytum officinale silicon dioxide silicon dioxide sus scrofa ligament sus scrofa ligament sus scrofa meniscus sus scrofa meniscus sus scrofa parathyroid gland sus scrofa parathyroid gland sus scrofa vein sus scrofa vein water toxicodendron pubescens leaf toxicodendron pubescens leaf arnica montana arnica montana bos taurus mesenchyme bos taurus mesenchyme bos taurus lymph vessel bos taurus lymph vessel bos taurus intervertebral disc bos taurus intervertebral disc tribasic calcium phosphate phosphate ion sus scrofa cartilage sus scrofa cartilage formic acid formic acid calcium hexafluorosilicate calcium hexafluorosilicate pinus mugo leafy twig pinus mugo leafy twig ascorbic acid ascorbic acid sus scrofa joint capsule sus scrofa joint capsule comfrey root comfrey root alcohol frangula californica bark frangula californica bark ruta graveolens flowering top ruta graveolens flowering top

Indications and Usage:

Uses: for temporary relief of minor: joint aches* swelling* bruises* stiff ligaments* *claims based on traditional homeopathic practice, not accepted medical evidence. not fda evaluated.

Warnings:

If pregnant or breastfeeding , ask a health professional before use. do not use if clear seal over the cap is broken or missing. keep out of reach of children. in case of overdose, get medical help or contact a poison control center right away. stop use and ask a doctor if joint aches, swelling, bruises, stiff ligaments, or other symptoms do not improve within 7 days or are accompanied by fever.

Dosage and Administration:

Directions: adults & children ages 12 years and over: take 5 drops under the tongue 1-3 times a day, or as directed by your healthcare professional. consult a physician for use in children under 12 years of age.

Stop Use:

Stop use and ask a doctor if joint aches, swelling, bruises, stiff ligaments, or other symptoms do not improve within 7 days or are accompanied by fever.

Package Label Principal Display Panel:

Futureplex® c07 antitox® strong ligaments & joints homeopathic formula joint aches* swelling* 1 fl oz (30 ml) alcohol 20% by volume c0721-0219

Further Questions:

Distributed by apex energetics. questions? 16592 hale ave., irvine, ca 92606, usa


Comments/ Reviews:

* Data of this site is collected from www.fda.gov. This page is for informational purposes only. Always consult your physician with any questions you may have regarding a medical condition.